Clinical trial
Alterations of Immunologic Mediators During Severe Sepsis
NCT00484146 · Klinikum St. Georg gGmbH, Other · Terminated
Key facts
| NCT number | NCT00484146 |
|---|---|
| Title | Alterations of Immunologic Mediators During Severe Sepsis |
| Official title | Alterations of Immunologic Mediators During Severe Sepsis |
| Acronym | LAVISS_01 |
| Lead sponsor | Klinikum St. Georg gGmbH, Other |
| Collaborators | University of Halle Medical Faculty |
| Status | Terminated |
| Study type | Observational |
| Conditions | Severe Sepsis |
| Enrollment | 20 |
| Start date | Jun 1, 2006 |
| Primary completion | Dec 1, 2012 |
| Completion | Dec 1, 2012 |
| First posted | Jun 8, 2007 |
| Last update posted | Feb 9, 2017 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: